Home
About Us
About Company
Our Values
Our Capabilities
Infrastructures
Recognitions
Products & Services
API Intermediates
Fine Chemicals and Reagents
Research & Development
Business Development
Export & Import
Clients
Media
Brochure
Photo Gallery
Investors
Disclosures Under Regulation 46 of the LODR
CSR
Shareholders Communique
Other Information
Contact us
Contact Us
Careers
Scheme Of Demerger
home
>
Investors >
Scheme Of Demerger
> Final Scheme
Financials
Share Price
Scheme Of Demerger
BSE Trading Permission Letter
NSE Trading Permission Letter
Board Meeting Extracts for approval of IM
Certificate Of Incorporation
SEBI Relaxation Letter
NSDL Tripartire Agr
Board Rresolution for Approval of Scheme
CDSL Ttripartire Agr
Audit Committee Extracts for Approval of IM
Special Tax Benefit Statement
MOA and AOA
Final Scheme
Fairness Opinion
Valuation report
NCLT Order to Convene Meetings
Ortin Laboratories Equity Shareholders Notice
Ortin Laboratories Sundry Creditors Notice
Exchange Observation Letters
Approved Scheme Arrangement
NCLT Order of Demerger
Principle Approval from BSE
Principle Approval from NSE
In Principle Approval from BSE
In Principle Approval from NSE
Final Scheme
View Large Image